United States coronavirus vaccine market is expected to grow at an impressive rate for the next five years. Coronavirus is an infectious disease and once it infects one person, it spreads at a rapid rate to other people. Coronavirus has spread all over the world and in March 2020, World Health Organization declared coronavirus as a pandemic. Vaccination is an effective way to prevent the spread the pathogens as it reduces the risk of infection by training the body to recognize the infecting virus and prepare the antibodies present in the body to fight against the spread of disease inside the body. Increase in daily death rate of people suffering from coronavirus as it weakens the immune system of body is expected to fuel the coronavirus vaccine market. A large number of people are getting affected by the coronavirus thereby there is huge burden on the healthcare industry and professional who are taking care of patients admitted into the hospital is creating the need for vaccines so as to limit the spread of coronavirus in United States. To fight the novel coronavirus, leading authorities announced lockdown restrictions and imposed a set of precautionary measures and guidelines to ensure the safety of its citizens. Citizens started maintaining social distance and taking all necessary precautions which led to the shutdown of manufacturing units and industries resulting in a major hit on the economic growth of United States.

United States coronavirus vaccine market is segmented into type, required number of does, patient type, end user, vehicle type, regional distribution, and company. Based on type, market is further bifurcated into mRNA based and vector based. mRNA based vaccine is expected to witness growth for the forecast period. All vaccines in United States are tested and found to be effective and safe against novel coronavirus. mRNA are new type of vaccines which teaches cells to make proteins which triggers the immune system of the body to fight against the virus. Moderna developed first mRNA vaccine and took record time to complete the time from vaccine design and vaccine trials. These vaccines are more affordable, adaptable, faster, and easy to produce on a large scale than its other counterpart vaccines.

The major players operating in the United States coronavirus vaccine market are Pfizer Inc., Moderna Inc., Johnson & Johnson, BioNTech SE, Novavax, Inc., among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze the historical growth of the market size of United States coronavirus vaccine market from 2016 to 2019.
  • To estimate and forecast the market size of United States coronavirus vaccine market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast United States coronavirus vaccine market based on type, required number of doses, patient type, end user, regional distribution, and company.
  • To identify dominant region or segment in the United States coronavirus vaccine.
  • To identify drivers and challenges for United States coronavirus vaccine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States coronavirus vaccine market.
  • To identify and analyze the profile of leading players operating in United States coronavirus vaccine market.
  • To identify key sustainable strategies adopted by market players in United States coronavirus vaccine market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of United States coronavirus vaccine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Coronavirus vaccine manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to coronavirus vaccine market.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United States coronavirus vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         United States Coronavirus Vaccine Market, By Type:

    • mRNA Based
    • Vector Based
  • United States Coronavirus Vaccine Market, By Required Number of Doses:
    • Two
    • One
  • United States Coronavirus Vaccine Market, By Patient Type:
    • Adult
    • Pediatric
  • United States Coronavirus Vaccine Market, By End User:
    • Hospitals
    • Clinics
    • Research Institutes
    • Others
  • United States Coronavirus Vaccine Market, By Region:
    • South
    • West
    • Mid-West
    • North East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States coronavirus vaccine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
United States coronavirus vaccine market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

1.     Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Voice of Customers

5.    United States Coronavirus Vaccine Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Type (mRNA Based v/s Vector Based)

5.2.2.     By Required Number of Doses (Two v/s One)

5.2.3.     By Patient Type (Adult v/s Pediatric)

5.2.4.     By End User (Hospitals, Clinics, Research Institutes, Others)

5.2.5.     By Region

5.2.6.     By Company (2020)

5.3.  Product Market Map

6.    United States mRNA Based Coronavirus Vaccine Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Required Number of Doses

6.2.2.     By Patient Type

6.2.3.     By End User

7.    United States Vector Based Coronavirus Vaccine Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Required Number of Doses

7.2.2.     By Patient Type

7.2.3.     By End User

8.    Market Dynamics

8.1.  Drivers

8.2.  Challenges

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

11.  Comparative Analysis of Approved Vaccines in the United States

12.  Vaccination Scenario in the United States

13.  Analysis of Prospective Vaccines

14.  Import-Export Analysis

15.  Pricing Analysis

16.  United States Economic Profile

17.  Competitive Landscape

17.1.              Competition Outlook

17.2.              Company Profiles

17.2.1.  Pfizer Inc.

17.2.2.  Moderna Inc.

17.2.3.  Johnson & Johnson

17.2.4.  BioNTech SE

17.2.5.  Novavax, Inc.

18.  Strategic Recommendations

19.  About Us & Disclaimer